StocksFundsScreenerSectorsWatchlists
SVRA

SVRA - Savara Inc Stock Price, Fair Value and News

5.17USD+0.13 (+2.58%)Market Closed

Market Summary

SVRA
USD5.17+0.13
Market Closed
2.58%

SVRA Stock Price

View Fullscreen

SVRA RSI Chart

SVRA Valuation

Market Cap

699.0M

Price/Earnings (Trailing)

-12.78

Price/Sales (Trailing)

3.0K

EV/EBITDA

-11.55

Price/Free Cashflow

-13.61

SVRA Price/Sales (Trailing)

SVRA Profitability

EBT Margin

-26821.79%

Return on Equity

-38.97%

Return on Assets

-30.8%

Free Cashflow Yield

-7.35%

SVRA Fundamentals

SVRA Revenue

Revenue (TTM)

257.0K

SVRA Earnings

Earnings (TTM)

-54.7M

Earnings Growth (Yr)

-56.3%

Earnings Growth (Qtr)

3.01%

Breaking Down SVRA Revenue

Last 7 days

8.1%

Last 30 days

7.4%

Last 90 days

18.8%

Trailing 12 Months

189.1%

How does SVRA drawdown profile look like?

SVRA Financial Health

Current Ratio

15.66

Debt/Equity

0.19

Debt/Cashflow

-1.94

SVRA Investor Care

Shares Dilution (1Y)

18.67%

Diluted EPS (TTM)

-0.33

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202022.3M14.9M7.6M257.0K
201900029.6M
201815.0M22.3M00
20177.7M000
2016140.5K227.0K313.5K400.0K
201500054.0K
2010000489.0K

Tracking the Latest Insider Buys and Sells of Savara Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Dec 28, 2023
elam nevan c
acquired
69,721
1.29695
53,758
-
Dec 28, 2023
elam nevan c
sold
-442,291
4.7131
-93,843
-
Dec 28, 2023
pauls matthew
sold
-395,900
4.7131
-84,000
chief executive officer
Dec 28, 2023
pauls matthew
gifted
-
-
-19,000
chief executive officer
Dec 28, 2023
lowrance david l
sold
-47,131
4.7131
-10,000
chief financial officer
Dec 15, 2023
lowrance david l
gifted
-
-
-20,000
chief financial officer
Dec 14, 2023
pauls matthew
sold (taxes)
-488,076
4.45
-109,680
chief executive officer
Dec 14, 2023
ramsay david a
acquired
-
-
22,500
-
Dec 14, 2023
hawkins richard j
acquired
-
-
22,500
-
Dec 14, 2023
elam nevan c
acquired
-
-
22,500
-

1–10 of 50

Which funds bought or sold SVRA recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 09, 2024
Halpern Financial, Inc.
unchanged
-
1.00
10.00
-%
Apr 05, 2024
GAMMA Investing LLC
new
-
299
299
-%
Mar 22, 2024
PNC FINANCIAL SERVICES GROUP, INC.
new
-
61.00
61.00
-%
Mar 13, 2024
Sivia Capital Partners, LLC
new
-
169,200
169,200
0.13%
Mar 11, 2024
VANGUARD GROUP INC
added
2.61
6,010,060
27,800,300
-%
Mar 01, 2024
GOLDMAN SACHS GROUP INC
added
188
861,887
1,195,680
-%
Feb 28, 2024
AMERICAN INTERNATIONAL GROUP, INC.
reduced
-0.4
40,626
211,044
-%
Feb 20, 2024
Quarry LP
new
-
21,150
21,150
-%
Feb 16, 2024
PRICE T ROWE ASSOCIATES INC /MD/
added
6.39
33,000
137,000
-%
Feb 15, 2024
Farther Finance Advisors, LLC
new
-
121,175
121,175
0.01%

1–10 of 46

Are Funds Buying or Selling SVRA?

Are funds buying SVRA calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own SVRA
No. of Funds

Unveiling Savara Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Apr 12, 2024
bain capital life sciences fund ii, l.p.
9.99%
14,565,457
SC 13D/A
Feb 14, 2024
zambon spa
3.46%
4,680,000
SC 13G/A
Feb 14, 2024
venrock healthcare capital partners ii, l.p.
2.6%
3,500,000
SC 13G/A
Feb 13, 2024
caxton corp
0.3%
353,441
SC 13G/A
Feb 13, 2024
prudential financial inc
7.23%
0
SC 13G
Feb 08, 2024
jennison associates llc
6.5%
8,815,358
SC 13G
Feb 07, 2024
adage capital partners gp, l.l.c.
5.64%
7,637,930
SC 13G/A
Feb 01, 2024
farallon capital partners, l.p.
1.9%
2,542,599
SC 13G/A
Jan 31, 2024
blackrock inc.
5.4%
7,261,530
SC 13G
Jul 26, 2023
growth equity opportunities 17, llc
18.1%
24,471,264
SC 13D/A

Recent SEC filings of Savara Inc

View All Filings
Date Filed Form Type Document
Apr 12, 2024
SC 13D/A
13D - Major Acquisition
Apr 12, 2024
PRE 14A
PRE 14A
Apr 12, 2024
8-K
Current Report
Mar 29, 2024
3
Insider Trading
Mar 07, 2024
S-8
Employee Benefits Plan
Mar 07, 2024
10-K
Annual Report
Feb 16, 2024
8-K
Current Report
Feb 14, 2024
SC 13G/A
Major Ownership Report
Feb 14, 2024
SC 13G/A
Major Ownership Report
Feb 13, 2024
SC 13G/A
Major Ownership Report

Peers (Alternatives to Savara Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
39.7B
6.8B
0.01% -33.89%
-8.42
5.79
-64.45% -156.37%
22.4B
152.6K
-0.77% 465779.94%
-2.4K
146.8K
- -9.98%
18.6B
1.8B
-1.06% -27.57%
-42.25
10.17
76.23% 61.08%
17.3B
2.4B
9.12% -7.56%
103
7.14
15.42% 18.43%
12.0B
3.7B
-8.48% -28.30%
20.07
3.25
8.87% 75.42%
MID-CAP
6.2B
396.6M
-9.27% -36.41%
-11.74
15.65
425.83% 18.94%
4.5B
-
-6.46% 74.90%
-6.94
60.35
54.84% -34.79%
3.2B
270.6M
-9.62% -0.34%
-13.52
11.95
440.80% -27.84%
3.0B
240.7M
-15.06% -21.14%
-10.03
12.36
-1.03% -92.09%
2.8B
726.4M
-8.60% -6.11%
-45.41
3.83
40.45% 71.62%
SMALL-CAP
1.8B
398.2M
-4.17% -12.95%
25.42
4.56
85.90% -14.05%
576.6M
983.7M
-22.12% -55.02%
-1.06
0.59
-50.36% 17.16%
448.6M
881.7K
-2.13% 345.78%
-10.06
466.16
-77.61% -5.33%
256.8M
4.9M
2.33% 7.75%
-1.9
52.78
-54.97% 51.72%
6.7M
2.1M
82.86% 81.13%
-0.25
2.14
-13.45% 66.37%

Savara Inc News

Latest updates
Defense World • 07 Apr 2024 • 10:14 am
MarketBeat • 03 Apr 2024 • 07:00 am
InvestorPlace • 07 Mar 2024 • 08:00 am
InvestorsObserver • 05 Mar 2024 • 08:00 am
CNN • 01 Mar 2024 • 02:16 pm
Business Wire • 2 months ago
Simply Wall St • 3 months ago
Yahoo Finance • 7 months ago

Savara Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In null)
Income Statement (Quarterly)
Description(%) Q/Q2020Q42020Q32020Q22020Q12019Q42018Q22018Q12017Q12016Q42016Q32016Q22016Q12015Q42010Q4
Revenue--------94.0040045.00----
Operating Expenses17.9%13,01311,0419,26416,24031,50911,90732,107-------
  S&GA Expenses-48.1%2,7905,3753,1172,9823,2962,4861,769-------
EBITDA Margin-9.00-------------
Interest Expenses-----503113334-------
Income Taxes-------277-4,555-237------
Earnings Before Taxes----9,389-15,421-31,719-11,594-31,404-5,211-1,949-3,227-2,051---
EBT Margin-Infinity%-268.22*-------------
Net Income-24.2%-13,741-11,063-9,389-15,421-31,719-11,593-26,849-------
Net Income Margin-Infinity%-193.05*-------------
Free Cashflow-Infinity%-12,305-------------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets-2.5%17818212012914014815716617718719620898.00109115120136141147148152
  Current Assets-2.4%16617010811812913714515516517518319585.0096.00103107124108114108113
    Cash Equivalents-4.0%27.0028.0023.0034.0052.0012095.0079.0034.0045.0041.0056.0023.0035.0047.0035.0050.0018.0017.0026.0024.00
  Net PPE-2.5%0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.001.00
  Goodwill------------------19.0019.0027.0027.00
Liabilities4.7%37.0036.0032.0031.0032.0031.0030.0030.0032.0032.0031.0033.0033.0033.0031.0033.0035.0034.0035.0046.0044.00
  Current Liabilities18.2%11.009.006.005.006.005.004.0016.0015.0011.006.007.008.008.006.008.0011.008.009.009.007.00
  Long Term Debt-100.0%-26.0026.0026.0026.0026.0026.0013.0017.0021.0025.0025.0025.00--------
    LT Debt, Current--------13.008.004.00-----------
    LT Debt, Non Current0.3%26.0026.0026.0026.0026.0026.0026.0013.0017.0021.0025.0025.0025.00--------
Shareholder's Equity-4.2%14014788.0098.0010811712713614415516517564.0077.0084.0087.00102107113102108
  Retained Earnings-4.3%-393-377-360-349-338-328-318-308-300-289-278-267-257-243-232-223-207-176-163-141-129
  Additional Paid-In Capital1.8%534525449448447446446445445444443442321320316311310283276244238
Shares Outstanding2.1%13813511411411415315315311415311577.0054.00--------
Float-------159---180---116---78.00--
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations-17.9%-15,561-13,200-10,274-12,026-8,697-8,162-9,316-8,425-9,363-8,927-12,194-9,597-12,300-6,705-7,752-13,079-9,946-11,413-12,905-10,859-10,493
  Share Based Compensation36.8%1,3619959588645614504565748536907719464391,9311,1751,9311,1491,1461,1471,000945
Cashflow From Investing111.6%6,571-56,586-1,006-6,095-59,21132,99625,19553,665-1,26812,983-3,432-77,739-381-6,86118,080-1,78516,7516,590-14,9217,320869
Cashflow From Financing-89.4%7,89574,75510426.001.00-1.0088.00-1.006.0010.00324120,466-1,8272,328-46625,2485,70819,0564,8969,096

SVRA Income Statement

2023-12-31
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Operating expenses:  
Research and development$ 44,262$ 27,879
General and administrative15,66810,929
Depreciation and amortization7731
Total operating expenses60,00738,839
Loss from operations(60,007)(38,839)
Other income (expense), net:  
Interest income (expense), net4,436(88)
Foreign currency exchange gain (loss)76(19)
Tax credit income797796
Total other income (expense), net5,309689
Net loss$ (54,698)$ (38,150)
Net loss per share:  
Basic$ (0.33)$ (0.25)
Diluted$ (0.33)$ (0.25)
Weighted-average common shares outstanding:  
Basic165,204,652152,771,817
Diluted165,204,652152,771,817
Other comprehensive income (loss):  
Gain (loss) on foreign currency translation$ 133$ (648)
Unrealized gain on short-term investments20138
Total comprehensive loss$ (54,364)$ (38,760)

SVRA Balance Sheet

2023-12-31
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 26,585$ 52,100
Short-term investments135,73473,776
Prepaid expenses and other current assets3,6283,078
Total current assets165,947128,954
Property and equipment, net27051
In-process R&D10,96010,656
Other non-current assets387116
Total assets177,564139,777
Current liabilities:  
Accounts payable3,5041,334
Accrued expenses and other current liabilities7,0934,533
Total current liabilities10,5975,867
Long-term liabilities:  
Long-term debt26,34826,078
Other long-term liabilities24754
Total liabilities37,19231,999
Commitments and contingencies (Note 10) 
Stockholders’ equity:  
Common stock, $0.001 par value, 300,000,000 shares authorized as of December 31, 2023 and 2022, respectively; 138,143,545 and 114,046,345 shares issued and outstanding as of December 31, 2023 and 2022, respectively140116
Additional paid-in capital533,872446,938
Accumulated other comprehensive loss(271)(605)
Accumulated deficit(393,369)(338,671)
Total stockholders’ equity140,372107,778
Total liabilities and stockholders' equity$ 177,564$ 139,777
SVRA
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. is headquartered in Austin, Texas.
 CEO
 WEBSITEsavarapharma.com
 INDUSTRYBiotechnology
 EMPLOYEES28

Savara Inc Frequently Asked Questions


What is the ticker symbol for Savara Inc? What does SVRA stand for in stocks?

SVRA is the stock ticker symbol of Savara Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Savara Inc (SVRA)?

As of Mon Apr 15 2024, market cap of Savara Inc is 699.03 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of SVRA stock?

You can check SVRA's fair value in chart for subscribers.

What is the fair value of SVRA stock?

You can check SVRA's fair value in chart for subscribers. The fair value of Savara Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Savara Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for SVRA so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Savara Inc a good stock to buy?

The fair value guage provides a quick view whether SVRA is over valued or under valued. Whether Savara Inc is cheap or expensive depends on the assumptions which impact Savara Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for SVRA.

What is Savara Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Mon Apr 15 2024, SVRA's PE ratio (Price to Earnings) is -12.78 and Price to Sales (PS) ratio is 3 Thousand. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. SVRA PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Savara Inc's stock?

In the past 10 years, Savara Inc has provided 0.246 (multiply by 100 for percentage) rate of return.